日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial

伊沙妥昔单抗、卡非佐米、来那度胺和地塞米松诱导治疗新诊断的多发性骨髓瘤:MIDAS试验分析

Perrot, Aurore; Touzeau, Cyrille; Lambert, Jerome; Hulin, Cyrille; Caillot, Denis; Karlin, Lionel; Arnulf, Bertrand; Rey, Philippe; Garderet, Laurent; Macro, Margaret; Escoffre Barbe, Martine; Gay, Julie; Chalopin, Thomas; Gounot, Romain; Schiano, Jean-Marc; Tiab, Mourad; Mohty, Mohamad; Kuhnowski, Frederique; Fontan, Jean; Manier, Salomon; Orsini-Piocelle, Frederique; Vincent, Laure; Rigaudeau, Sophie; Leleu, Xavier; Hebraud, Benjamin; Flet, Laurent; Malfuson, Jean-Valere; Jacquet, Caroline; Chaoui, Driss; Meuleman, Nathalie; Abarah, Wajed; Montes, Lydia; Benramdane, Riad; Sonntag, Cecile; Zerazhi, Hacene; Danu, Alina; Allangba, Olivier; Dib, Mamoun; Roussel, Murielle; Cereja, Sophie; Depaus, Julien; Branche, Nicolas; Demarquette, Helene; Richez, Valentine; Cherel, Brieuc; Frenzel, Laurent; Vekemans, Marie-Christiane; Bigot, Noemie; Avet-Loiseau, Herve; Corre, Jill; Moreau, Philippe

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

在适合移植的新诊断多发性骨髓瘤患者中,使用硼替佐米、沙利度胺和地塞米松联合或不联合达雷妥尤单抗治疗,随后进行达雷妥尤单抗维持治疗或观察:CASSIOPEIA 随机对照 3 期试验的长期随访

Moreau, Philippe; Hulin, Cyrille; Perrot, Aurore; Arnulf, Bertrand; Belhadj, Karim; Benboubker, Lotfi; Zweegman, Sonja; Caillon, Hélène; Caillot, Denis; Avet-Loiseau, Hervé; Delforge, Michel; Dejoie, Thomas; Facon, Thierry; Sonntag, Cécile; Fontan, Jean; Mohty, Mohamad; Jie, Kon-Siong; Karlin, Lionel; Kuhnowski, Frédérique; Lambert, Jérôme; Leleu, Xavier; Macro, Margaret; Orsini-Piocelle, Frédérique; Roussel, Murielle; Schiano de Colella, Jean Marc; van de Donk, Niels Wcj; Wuillème, Soraya; Broijl, Annemiek; Touzeau, Cyrille; Tiab, Mourad; Marolleau, Jean-Pierre; Meuleman, Nathalie; Vekemans, Marie-Christiane; Westerman, Matthijs; Klein, Saskia K; Levin, Mark-David; Offner, Fritz; Escoffre-Barbe, Martine; Eveillard, Jean-Richard; Garidi, Réda; Hua, Winnie; Wang, Jianping; Tuozzo, Alba; de Boer, Carla; Rowe, Melissa; Vanquickelberghe, Veronique; Carson, Robin; Vermeulen, Jessica; Corre, Jill; Sonneveld, Pieter

EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition

滤泡性淋巴瘤中的 EZH2 突变会扭曲 H3K27me3 谱并改变对 PRC2 抑制的转录反应

Pierre Romero #, Laia Richart #, Setareh Aflaki, Ambre Petitalot, Megan Burton, Audrey Michaud, Julien Masliah-Planchon, Frédérique Kuhnowski, Samuel Le Cam, Carlos Baliñas-Gavira, Céline Méaudre, Armelle Luscan, Abderaouf Hamza, Patricia Legoix, Anne Vincent-Salomon, Michel Wassef, Daniel Holoch, R

Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study

在3期CASSIOPEIA研究中,接受达雷妥尤单抗+硼替佐米/沙利度胺/地塞米松治疗的符合移植条件的新诊断多发性骨髓瘤患者的干细胞产量和移植情况

Hulin, Cyrille; Offner, Fritz; Moreau, Philippe; Roussel, Murielle; Belhadj, Karim; Benboubker, Lotfi; Caillot, Denis; Facon, Thierry; Garderet, Laurent; Kuhnowski, Frédérique; Stoppa, Anne-Marie; Kolb, Brigitte; Tiab, Mourad; Jie, Kon-Siong; Westerman, Matthijs; Lambert, Jérôme; Pei, Lixia; Vanquickelberghe, Veronique; De Boer, Carla; Vermeulen, Jessica; Kampfenkel, Tobias; Sonneveld, Pieter; Van de Donk, Niels W C J